{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:05:07Z","timestamp":1772107507185,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T00:00:00Z","timestamp":1545523200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T00:00:00Z","timestamp":1545523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503156"],"award-info":[{"award-number":["81503156"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601347"],"award-info":[{"award-number":["81601347"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2014A030310096"],"award-info":[{"award-number":["2014A030310096"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Public Welfare Research and Capacity Building Fund of Guangdong","award":["2016A020218006"],"award-info":[{"award-number":["2016A020218006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1111\/jcpt.12794","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T04:29:48Z","timestamp":1545625788000},"page":"318-326","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of efficacy and safety between febuxostat and allopurinol in early post-renal transplant recipients with new onset of hyperuricemia"],"prefix":"10.1155","volume":"44","author":[{"given":"Xiaoju","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital; Sun Yat-sen University; Guangzhou China"},{"name":"Department of Pharmacy, The First Affiliated Hospital; Guangxi Medical University; Nanning China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjie","family":"Li","sequence":"additional","affiliation":[{"name":"Center of Reproductive Medicine, The Sixth Affiliated Hospital; Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Fu","sequence":"additional","affiliation":[{"name":"Organ Transplant Center, The First Affiliated Hospital; Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longshan","family":"Liu","sequence":"additional","affiliation":[{"name":"Organ Transplant Center, The First Affiliated Hospital; Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital; Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital; Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital; Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changxi","family":"Wang","sequence":"additional","affiliation":[{"name":"Organ Transplant Center, The First Affiliated Hospital; Sun Yat-sen University; Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,12,23]]},"reference":[{"issue":"5","key":"10.1111\/jcpt.12794-BIB0001|jcpt12794-cit-0001","doi-asserted-by":"crossref","first-page":"e0176786","DOI":"10.1371\/journal.pone.0176786","article-title":"Early onset hyperuricemia is a prognostic marker for kidney graft failure: Propensity score matching analysis in a Korean multicenter cohort","volume":"12","author":"Han","year":"2017","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1111\/jcpt.12794-BIB0002|jcpt12794-cit-0002","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semnephrol.2004.09.008","article-title":"Uric acid and transplantation","volume":"25","author":"Mazzali","year":"2005","journal-title":"Semin Nephrol"},{"issue":"5","key":"10.1111\/jcpt.12794-BIB0003|jcpt12794-cit-0003","first-page":"679","article-title":"Drug-induced hyperuricaemia and gout","volume":"56","author":"Ben Salem","year":"2017","journal-title":"Rheumatology (Oxford, England)"},{"issue":"5","key":"10.1111\/jcpt.12794-BIB0004|jcpt12794-cit-0004","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1681\/ASN.V115974","article-title":"Renal transplant-associated hyperuricemia and gout","volume":"11","author":"Clive","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1111\/jcpt.12794-BIB0005|jcpt12794-cit-0005","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/j.ajkd.2017.08.017","article-title":"Uric acid and the risks of kidney failure and death in individuals with CKD","volume":"71","author":"Srivastava","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1111\/jcpt.12794-BIB0006|jcpt12794-cit-0006","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000481460","article-title":"Impact of uric acid levels on kidney disease progression","volume":"46","author":"Rincon-Choles","year":"2017","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1111\/jcpt.12794-BIB0007|jcpt12794-cit-0007","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/TP.0b013e3181814f5b","article-title":"Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy","volume":"86","author":"Akalin","year":"2008","journal-title":"Transplantation"},{"issue":"9","key":"10.1111\/jcpt.12794-BIB0008|jcpt12794-cit-0008","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1600-6143.2011.03613.x","article-title":"Association of serum uric acid with graft survival after kidney transplantation: a time-varying analysis","volume":"11","author":"Haririan","year":"2011","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1111\/jcpt.12794-BIB0009|jcpt12794-cit-0009","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/TP.0b013e3181c73c18","article-title":"The independent association between serum uric acid and graft outcomes after kidney transplantation","volume":"89","author":"Haririan","year":"2010","journal-title":"Transplantation"},{"issue":"6","key":"10.1111\/jcpt.12794-BIB0010|jcpt12794-cit-0010","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.amjcard.2008.11.042","article-title":"Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk","volume":"103","author":"Bandukwala","year":"2009","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1111\/jcpt.12794-BIB0011|jcpt12794-cit-0011","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1093\/ndt\/gft029","article-title":"Uric acid and chronic kidney disease: which is chasing which?","volume":"28","author":"Johnson","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1111\/jcpt.12794-BIB0012|jcpt12794-cit-0012","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21946","article-title":"Association of a reactive intermediate derived from 1',6-dihydroxy metabolite with benzbromarone-induced hepatotoxicity","volume":"31","author":"Yoshida","year":"2017","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"10.1111\/jcpt.12794-BIB0013|jcpt12794-cit-0013","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1111\/jcpt.12794-BIB0014|jcpt12794-cit-0014","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.semarthrit.2013.05.004","article-title":"A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout","volume":"43","author":"Faruque","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1111\/jcpt.12794-BIB0015|jcpt12794-cit-0015","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1053\/j.ajkd.2014.11.016","article-title":"Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial","volume":"65","author":"Goicoechea","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1111\/jcpt.12794-BIB0016|jcpt12794-cit-0016","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s10067-014-2745-5","article-title":"Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease","volume":"33","author":"Tsuruta","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1111\/jcpt.12794-BIB0017|jcpt12794-cit-0017","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s10157-015-1095-1","article-title":"Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial","volume":"19","author":"Tanaka","year":"2015","journal-title":"Clin Exp Nephrol"},{"issue":"8","key":"10.1111\/jcpt.12794-BIB0018|jcpt12794-cit-0018","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3346\/jkms.2014.29.8.1077","article-title":"Four-week effects of allopurinol and febuxostat treatments on blood pressure and serum creatinine level in gouty men","volume":"29","author":"Kim","year":"2014","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.1111\/jcpt.12794-BIB0019|jcpt12794-cit-0019","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jjcc.2014.12.017","article-title":"Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients with chronic kidney disease (NU-FLASH trial for CKD)","volume":"66","author":"Sezai","year":"2015","journal-title":"J Cardiol"},{"issue":"3","key":"10.1111\/jcpt.12794-BIB0020|jcpt12794-cit-0020","first-page":"190","article-title":"Effect of allopurinol on slowing allograft functional decline in kidney transplant recipients","volume":"12","author":"Osadchuk","year":"2014","journal-title":"Exp Clin Transplant"},{"issue":"2","key":"10.1111\/jcpt.12794-BIB0021|jcpt12794-cit-0021","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.transproceed.2013.09.045","article-title":"Efficacy and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase for the treatment of hyperuricemia in kidney transplant recipients","volume":"46","author":"Tojimbara","year":"2014","journal-title":"Transpl Proc"},{"issue":"4","key":"10.1111\/jcpt.12794-BIB0022|jcpt12794-cit-0022","first-page":"401","article-title":"Efficacy and safety of febuxostat in kidney transplant patients","volume":"16","author":"Baek","year":"2018","journal-title":"Exp Clin Transplant"},{"issue":"23","key":"10.1111\/jcpt.12794-BIB0023|jcpt12794-cit-0023","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function-measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12794-BIB0024|jcpt12794-cit-0024","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/DDDT.S56597","article-title":"Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients","volume":"8","author":"Sofue","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"10.1111\/jcpt.12794-BIB0025|jcpt12794-cit-0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13075-015-0624-3","article-title":"Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort","volume":"17","author":"Singh","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1111\/jcpt.12794-BIB0026|jcpt12794-cit-0026","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.ajkd.2015.05.017","article-title":"Efficacy of febuxostat for slowing the GFR decline in patients with CKD and asymptomatic hyperuricemia: a 6-month, double-blind, randomized, placebo-controlled trial","volume":"66","author":"Sircar","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1111\/jcpt.12794-BIB0027|jcpt12794-cit-0027","doi-asserted-by":"crossref","first-page":"c108","DOI":"10.1159\/000254383","article-title":"Suitability of the IDMS-traceable MDRD equation method to estimate GFR in early postoperative renal transplant recipients","volume":"114","author":"Yeo","year":"2010","journal-title":"Nephron Clin Pract"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12794","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12794\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:07Z","timestamp":1671818647000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,23]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12794","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,23]]}}}